Genetic diversity of circulating rotavirus strains in Tanzania prior to the introduction of vaccination by Moyo, Sabrina John et al.
Genetic Diversity of Circulating Rotavirus Strains in
Tanzania Prior to the Introduction of Vaccination
Sabrina J. Moyo1,2*, Bjørn Blomberg1,3, Kurt Hanevik1,3, Oyvind Kommedal4, Kirsti Vainio5,
Samuel Y. Maselle2, Nina Langeland1,6
1Department of Clinical Science, University of Bergen, Bergen, Norway, 2Department of Microbiology and Immunology, Muhimbili University of Health and Allied
Sciences, Dar es Salaam, Tanzania, 3Centre for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway, 4Department of Microbiology, Haukeland
University Hospital, Bergen, Norway, 5Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway, 6Department of Medicine, Haukeland
University Hospital, Bergen, Norway
Abstract
Background: Tanzania currently rolls out vaccination against rotavirus-diarrhea, a major cause of child illness and death. As
the vaccine covers a limited number of rotavirus variants, this study describes the molecular epidemiology of rotavirus
among children under two years in Dar es Salaam, Tanzania, prior to implementation of vaccination.
Methods: Stool specimens, demographic and clinical information, were collected from 690 children admitted to hospital
due to diarrhea (cases) and 545 children without diarrhea (controls) during one year. Controls were inpatient or children
attending child health clinics. Rotavirus antigen was detected using ELISA and positive samples were typed by multiplex
semi-nested PCR and sequencing.
Results: The prevalence of rotavirus was higher in cases (32.5%) than in controls (7.7%, P,0.001). The most common G
genotypes were G1 followed by G8, G12, and G4 in cases and G1, G12 and G8 in controls. The Tanzanian G1 variants
displayed 94% similarity with the Rotarix vaccine G1 variant. The commonest P genotypes were P[8], P[4] and P[6], and the
commonest G/P combination G1 P[8] (n = 123), G8 P[4] and G12 P[6]. Overall, rotavirus prevalence was higher in cool (23.9%)
than hot months (17.1%) of the year (P = 0.012). We also observed significant seasonal variation of G genotypes. Rotavirus
was most frequently found in the age group of four to six months. The prevalence of rotavirus in cases was lower in stunted
children (28.9%) than in non-stunted children (40.1%, P = 0.003) and lower in HIV-infected (15.4%, 4/26) than in HIV-
uninfected children (55.3%, 42/76, P,0.001).
Conclusion: This pre-vaccination study shows predominance of genotype G1 in Tanzania, which is phylogenetically
distantly related to the vaccine strains. We confirm the emergence of genotype G8 and G12. Rotavirus infection and
circulating genotypes showed seasonal variation. This study also suggests that rotavirus may not be an opportunistic
pathogen in children infected with HIV.
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Introduction
Rotavirus is a major cause of severe dehydrating diarrhea both
in developed and developing countries [1,2]. The WHO rotavirus
surveillance networks estimates that more than a third of diarrhea
hospitalizations among children under five years of age is
attributed to rotavirus infection [3]. In 2008, rotavirus caused an
estimated 453000 deaths in children younger than five years, more
than half of which occurred in developing countries [4].
Due to the limited effect of sanitation-based strategies for
preventing the spread of the virus, several rotavirus vaccines have
been developed, out of which two oral vaccines (RotaTeq and
Rotarix) have been licensed. The introduction of rotavirus
vaccines in developed countries has significantly reduced diarrheal
mortality and hospitalizations [5–10]. A live attenuated monova-
lent vaccine (Rotarix) was introduced in Tanzania early 2013 and
is implemented in the national childhood vaccination schedule.
Rotaviruses are non-enveloped viruses of the genus Reoviridae
[11]. The viral genome consists of double stranded segmented
RNA enclosed in three protein layers. The middle-layer major
capsid protein, VP6 determines the seven major groups (A through
G) of rotavirus. Most human infections are caused by group A
rotaviruses [12]. The outer capsid of rotavirus is composed of two
structural proteins, VP4 (a protease cleaved protein, P protein) and
VP7 (a glycoprotein, G protein), which independently elicit
protective neutralizing antibodies and serve as the basis of a dual
serotyping system [13–15]. At least 27 G genotypes and 35 P
genotypes have been identified in human rotaviruses [16], whereof
genotypes G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8] are
responsible for 80–90% of the childhood rotavirus disease burden
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globally [17]. Rotavirus G12 has recently been identified as an
emerging genotype [9]. But from the African continent, G12 in
combination with P[6] or P[8] has been reported from only South
Africa, Malawi and Nigeria [18–20]. Rotavirus G8 genotype has
been reported from humans worldwide with high prevalence in
some African countries [17,21–28].
Rotavirus infection is common in both temperate and tropical
climatic areas and shows distinct seasonality [29]. Before the
discovery of the viral agent it was called ‘winter diarrhea and
winter gastroenteritis’ in some parts of the world [29–31]. There is
an increase in attention to the nature of rotavirus disease in
relation to seasonality, and this has been well documented in
temperate countries [32,33]. Recently two studies have also
demonstrated the inverse relationship between temperature and
rotavirus incidence in the tropics [29,34].
In Tanzania, it is estimated that rotavirus causes more than one
third of diarrheal disease hospitalizations and each year it kills
more than eight thousands children under five years of age [35]. In
a previous study conducted in 2005–2006 [36], we reported high
prevalence of rotavirus G9 among under-five children admitted
with diarrhea in Dar es Salaam. The present study provides an
update on the distribution of rotavirus G and P genotypes among
children with diarrhea (cases) and compares it with that from
children without diarrhea (controls) between August 2010 and July
2011. In addition we assessed the impact of HIV, clinical features
and seasonal variation on rotavirus infection. The findings provide
baseline information on rotavirus infection shortly before vaccine
introduction in Tanzania.
Material and Methods
Ethics Statement
This study received ethical approval from the Senate Research
and Publications Committee of Muhimbili University of Health
and Allied Sciences in Dar es Salaam, Tanzania and from the
Regional Committee for Medical and Health Research Ethics
(REK) in Norway. Permission was also obtained from the
respective hospital authorities where recruitment of study partic-
ipants took place (i.e. MNH, Amana and Temeke Hospitals).
Written informed consent was obtained from the parent, next of
kin, caretaker, or guardian on behalf of all the minors/children
enrolled in the study.
Study Population
This study was conducted between August 2010 and July 2011
in Dar es Salaam Tanzania, a city with a population of about five
million. Sample collection was performed during two seasons,
starting in August 2010 and in March 2011, aiming for minimum
300 cases and 300 controls in each period. The target for cases was
reached in January 2011 and in June 2011, while enrollment of
controls continued in February 2011 and July 2011. A total of
1266 stool specimens were collected from children below two years
of age. Cases were children hospitalized due to diarrhea at three
major hospitals of Dar es Salaam; Muhimbili National Hospital
(MNH), Amana and Temeke Municipal Hospitals. MNH, with a
bed capacity of 1200, is the largest hospital in the country and
serves as a tertiary and national referral Hospital. Amana and
Temeke are Municipal district Hospitals of Dar es Salaam.
Controls included children below two years of age with no history
of diarrhea for one month prior to the study enrollment. These
were either children attending child health clinics for immuniza-
tion and growth monitoring (CHC, n = 310) or children admitted
to hospital due to diseases other than diarrhea (n = 235).
Inclusion Criteria Case Definition
Children admitted in the diarrhea wards with acute or persistent
diarrhea were included in the study. Diarrhea was defined as three
or more watery stools within 24 hours. An episode of diarrhea was
considered over when two consecutive days pass without diarrhea.
An episode of acute diarrhea was defined as diarrhea with
duration between 24 hours and less than 14 days. Persistent
diarrhea was defined as diarrhea for 14 days or more.
Controls included in the study were children without history of
diarrhea for one month prior to enrollment. Controls were not
matched by age and sex with cases.
Exclusion Criteria
Children above 24 months of age and cases that could not
provide stool sample on the day of admission were not included in
the study. Cases and controls whose parent or guardian did not
consent to participate in the study were excluded.
Collection of Information from Children with Diarrhea
(Cases) and from Children without Diarrhea (Controls)
Recruitment of cases was done during the admission of the child
in the pediatric diarrhea wards of the study sites. A standardized
questionnaire was used to collect demographic and clinical
information, including age (date of birth), sex, place of residence,
parent/guardian level of education and history of antibiotic use
prior to admission. Consistency of stool (watery, bloody) and
duration of diarrhea was also recorded. The child’s length and
weight measurements were recorded. Additional clinical informa-
tion of patients, such as hydration status, as assessed on the day of
admission by the attending clinician, was obtained from patient
files together with HIV testing results. HIV testing was done by
HIV-DNA PCR at the Hospital laboratory (MNH) or research
laboratory at MUHAS, as previously described [37]. Potential
controls were enrolled during the recruitment of cases. The
questionnaire for controls did not have parameters for clinical
characteristics such as type of diarrhea and presence of
dehydration. In addition controls did not have diarrhea for one
month prior to the study enrollment.
Weight and Length Measurements
All children were weighed using a 25 kg Salter hanging scales
(CMS Weighing equipment, High Holborn, London, United
Kingdom). Weight was recorded to the nearest 0.1 kilogram.
Length was measured using standard length boards to the nearest
millimeter. Weight for age (WAZ), length for age (LAZ) and
weight for length (WLZ) Z-scores were calculated using EPI Info
(USD, Inc., Stone Mountain, GA). Children were categorized to
have normal nutritional status, mild or severe malnutrition using
Z-scores according to WHO criteria [38].
Specimen Collection
A single stool specimen was collected on inclusion from each
child using wide mouthed sterile plastic containers. One portion
was frozen at 270uC the same day as it was collected.
Rotavirus Detection
Rotavirus antigens were detected using the commercially
available ProSpecT Rotavirus ELISA kit (Oxoid, Hants, UK),
with 10% fecal suspensions according to the manufacturer’s
instructions.
Rotavirus Genotypes Prior to Vaccination
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Extraction of RNA
Fifty mg of rotavirus antigen-positive stool specimen were mixed
1:10 with Bacterial Lysis buffer (Roche Applied Science,
Mannheim, Germany), and centrifuged at 13.000 g for 3 minutes.
RNA was extracted from 200 mL supernatant using the Magna
Pure LC High Performance Total Nucleic Acid Isolation Kit
(Roche Applied Science, Mannheim, Germany).
Reverse Transcription, G and P-typing of Rotaviruses
Reverse transcription, G and P typing was done as described in
European Rotavirus Detection and Typing Methods version 4
[39]. Briefly a total of 40 mL of RNA extract was used as template
for reverse transcription with random primers. Rotavirus G an P
genotyping was performed using semi-nested type specific
multiplex PCR’s that could detect eight G genotypes (G1, G2,
G3, G4, G8, G9, G10 and G12) and six P-types P[4], P[6], P[8],
P[9], P[10] and P[11]. PCR products were subjected to
electrophoresis on a 2% agarose gel, stained with Gel Red, and
observed under ultraviolet light. The Rotavirus G and P genotypes
were determined by their specific size on the agarose gel. The non-
typeable rotavirus strains were further confirmed if they were
rotavirus using a single round rotavirus VP6 specific PCR.
Negative and positive controls were included in all PCR assays.
Sequencing of the VP7 and VP4 Gene of the Rotavirus
Positive Strains
Partial sequencing of the first round PCR-amplicons for the
VP7 gene was performed for all samples positive for rotavirus in
order to confirm the PCR G- typing results as described in the
European Rotavirus Detection and Typing Methods version 4
[39]. Randomly selected rotavirus positive isolates (33%) were
subjected to partial sequencing of the VP4 gene to confirm PCR
P-typing results. The sequencing of both VP4 and VP7 was done
using purified first round PCR products, on an ABI3730 machine
using BigDye (Applied Biosystems). The same primers as in the
PCR were used, both forward and reverse primers for VP7 gene
while only forward primers was used for VP4 gene.
Sequence and Phylogenetic Analysis of the VP7 Gene
Nucleotide sequences were analyzed using the RipSeq inter-
pretation software (iSentio Ltd., Bergen, Norway) and by the
nucleotide BLAST service (NCBI). The evolutionary distances
between Tanzanian strains, vaccine strains and the reference
strains from GenBank were investigated using pairwise compar-
ison from multiple sequence alignments using the Genius software
package (Biomatters) and the phylogenetic tree was constructed
using the UPGMA and Kimura two-parameter methods [40]. A
bootstrap resampling analysis was performed (1000 replicates) to
test tree reliability.
Nucleotide Sequence Accession Numbers
The DNA sequences for the VP7 genes of the study strains were
submitted directly to GenBank and were assigned accession
numbers from KF976838 to KF976860.
The DNA sequences for the VP4 genes of the study strains were
submitted directly to GenBank and were assigned accession
numbers from KF976815 to KF976837.
Statistical Analysis
Weight for age, length for age and weight for length Z-scores
were calculated using EPI Info (USD, Inc., Stone Mountain, GA,
USA). Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS for IBM-PC, release 18.0;
SPSS Inc., Chicago, IL, USA). Differences in proportions were
tested using the chi-square (x2) test. A p-value of ,0.05 was
considered significant. The association between rotavirus positiv-
ity, genotypes, clinical and demographic characteristics was
estimated as the odds ratio (OR) between rotavirus infected and
rotavirus uninfected individuals in a logistic regression model.
Factors from the univariate analysis were kept in the main logistic
regression model. A separate regression model including HIV as a
factor, employed manual, backwards, stepwise elimination of non-
significant factors (p$0.05).
Results
During the study period August 2010 to July 2011, a total of
1266 samples were collected. Among 1235 samples containing
adequate material for rotavirus detection, 690 were from children
with diarrhea and 545 were from controls (children without
diarrhea). There were 717 (58.1%) males and 517(41.9%) females.
Children were recruited from the districts Ilala (n = 634, 51.3%),
Kinondoni (n = 360, 29.1%) and Temeke (n = 241, 19.5%).
Prevalence of Rotavirus Infection and Distribution of G
and P Genotypes
Of the 1235 children with and without diarrhea included in the
study, rotavirus was detected in 266 children (21.5%) using
ELISA. The prevalence of rotavirus infection was significantly
higher in cases (32.5%, 224/690) than in controls (7.7%, 42/545,
P,0.01, OR = 5.8, 95%CI 4.045 to 8.192). The prevalence of
rotavirus did not differ statistically between controls from Child
Health Clinics (7.7%, 24/310) and hospital based controls (7.7%,
18/235, P.0.05).
Sequencing results detected rotavirus G8 in 33 cases, which
were misallocated to G12 when G genotype was assessed by PCR
alone. Therefore, all samples were G typed based on sequencing
results. A total of 211 specimens, which were successfully
sequenced were characterized to G genotypes, 190 cases and 21
controls. Out of eight rotavirus G genotypes searched for, only five
G genotypes were found. The most commonly detected G
genotype strains among cases were G1 (n = 131, 68.6%), followed
by G8 (n = 33, 17.3%), G12 (n = 21, 11.05%), G4 (n = 4, 2.1%)
and G9 (n = 1, 0.5%). Rotavirus genotype G1 was also common
among children without diarrhea (controls) accounting for 66.7%
followed by G12 (19.0%) and G8 (14.3%). Genotype G2, G3 and
G10 were not detected.
A total of 236 samples were P genotyped using RT-PCR, 211
were cases and 25 were controls. One third of 236 samples
underwent sequencing of the VP4 gene, which produced the same
results as RT-PCR. Out of six P genotypes searched for, only three
P genotypes were found. The commonest circulating P genotype
in cases was P[8] (n = 141, 66.8%) followed by P[4] (n = 40,
19.0%) and P[6] (n = 30, 14.2%). Rotavirus P[9], P[10]and P[11]
were not found. Table 1 shows G/P combinations for the 211
samples that were successfully typed for both G and P genotypes
(among the 236 P-typed samples, 25 could not be G-typed). The
commonest G/P combination in cases was G1P[8] accounting for
123 samples, followed by G8P[4] (n = 27) and G12P[6] (n = 21).
We found no rotavirus G or P genotype associated with
diarrhea. The common G and P genotypes circulating in children
with diarrhea were also common among children without diarrhea
as shown in Table 1. We did not find samples with multiple strains
of rotavirus.
Rotavirus Genotypes Prior to Vaccination
PLOS ONE | www.plosone.org 3 May 2014 | Volume 9 | Issue 5 | e97562
Analysis of VP7 Nucleotide Sequences
Phylogenetic analysis based on VP7 nucleotide sequences
showed that sequences varied by only 1–2% within the rotavirus
G1 strains detected in Tanzania (Fig. 1A). These GI genotypes
also showed 98–99% nucleotide similarity to G1 strains circulating
worldwide such as in Malawi, Bangladesh, Belgium and USA with
GenBank accession numbers JN591404, EF690754, EF690759,
HQ392309 and HM773752. Notably, only 94% similarity was
found between the Tanzanian G1genotype and the rotavirus
vaccine-strains RotaTeq (GU565057) and Rotarix (JN849114).
The rotavirus G8 strains in this study had 98–99% nucleotide
similarity with each other; they are also closely related (98%–99%
nucleotide similarity) to circulating rotavirus G8 strains in Kenya,
Malawi and USA with GenBank accession numbers EU488721,
FJ386444, JN591405, GQ496281, JF693231, KC215513. The
G12 genotypes in this study displayed nucleotide similarities above
99%. These rotavirus G12 strains were also closely related to
circulating G12 strains in Malawi, India and Nepal with GenBank
accession numbers EU573780, EF559260, AB263988 and
AB275292.
Analysis of VP4 Nucleotide Sequences
Comparison of VP4 nucleotide sequences from Tanzanian
strains and representatives of P-genotype strains from the
GenBank database are shown in figure 1B. Tanzanian P[8]
strains showed 98% nucleotide identity to each other and to
circulating P[8] reference strains from Australia, Brazil, USA and
Thailand with GenBank accession numbers JF490333, JX027920,
DQ857918, HM773758 and DQ674980. Nucleotide identities
between Tanzanian rotavirus P[4] strains and reference P[4]
strains from Malawi and Kenya was 98%. GenBank accession
numbers for P[4] reference strains are FJ386448 and HQ657141.
Tanzanian rotavirus P[6] strains were closely related to each other
with 99% nucleotide similarity and showed 98% nucleotide
identity to reference P[6] strains from Malawi, South Africa and
Bangladesh with GenBank accession numbers JN591402,
HQ657163, EF033340, DQ490554, DQ146663.
Seasonality of Rotavirus Infection and Rotavirus G-types
The prevalence of rotavirus detected varied significantly by
months in both cases and controls (P,0.001). When results were
divided into cool and hot months of the year i.e. May through
August vs. November through February, rotavirus prevalence
(both in cases and controls) was significantly higher in cool than
hot months (23.9% vs. 17.1%, P = 0.012, OR 1.52, 95% CI: 1.081
to 1.894: 1.09 to 2.11). As shown in Figure 1, there was also high
number of rotavirus detected among cases in the beginning of the
cool season i.e. April 2011 and between the cool and the hot
season, which are periods that coincide with rain season.
We also observed significant variations of G genotypes detection
in different months during the study period (P,0.001) as shown in
Figure 2. The commonest genotype G1 was detected in most
months of the study, with the highest peak in the month of April
2011, which is the beginning of the cool season and May 2011.
Genotypes G8 and G12 were detected in most months of the study
period, but genotype G9 was only detected in the month of
October 2010.
We compared rotavirus prevalence in studies conducted in
previous years in the same region but during different seasons of
the year. We observed high prevalence in studies conducted
during the cool months of the year [41,42] compared to studies
conducted in hot months of the year, Table 2 [36,43].
Association between Rotavirus Infection and HIV Status
A total of 421 children were tested for HIV, of these 33 and 388
tested HIV positive and negative respectively. In univariate
analysis, the prevalence of rotavirus infection was significantly
lower in HIV-infected (15.4%, 4/26) than in HIV-uninfected
children with diarrhea (cases) (55.3%, 42/76, P = 0.001, OR
0.152, 95% CI: 0.05–0.48). HIV status was not included in the
final regression model; because it would introduce a high number
of missing values as 54% rotavirus infected children were not
tested for HIV. A separate regression model was performed
including HIV status and other significant risk factors from the
univariate analysis (length for age, place of residence and type of
diarrhea). With stepwise, backwards removal of all non-significant
factors (P$0.05), rotavirus infection remained significantly nega-
tively associated with HIV infection (P = 0.027, OR 0.26, 95% CI:
0.08 to 0.85) and stunting (P = 0.005, OR 0.23, 95% CI: 0.08 to
0.63).
Among children without diarrhea (controls), the prevalence of
rotavirus was significantly higher in HIV-infected (28.6%, 2/7)
than in HIV-uninfected children (7.4%, 23/312, P = 0.039, OR
5.03, 95%CI: 0.92 to 27.35).
Table 1. Sequencing results of rotavirus G and P genotypes circulating in children with diarrhea (cases) and children without
diarrhea (controls) in Dar es Salaam, Tanzania (n = 211; 190 cases and 21 controls).
G1 G4 G8 G9 G12 Total P types N (%)
Cases
P4 7 2 27 0 0 36 (19.0%)
P6 1 2 6 0 21 30 (15.7%)
P8 123 0 0 1 0 124 (65.4%)
Total G types 131 (68.6%) 4 (2.1%) 33 (17.3%) 1 (0.5%) 22 (11.5%) 190 (100%)
Controls
P4 0 0 3 0 0 3 (14.3%)
P6 0 0 0 0 4 4 (19.0%)
P8 14 0 0 0 0 14 (66.7%)
Total G types 14 (66.7%) 0 3 (14.3%) 0 4 (19.0%) 21 (100%)
doi:10.1371/journal.pone.0097562.t001
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Figure 1. A and B. Phylogenetic trees of the rotavirus nucleotide sequence of the partial VP7 and VP4 genes. The phylogenetic tree:
Phylogenetic trees based on the nucleotide sequence of the partial VP7 gene (figure 1A) and VP4 gene (figure 1B) of rotaviruses from Tanzania with
known rotavirus reference strains from GenBank database and rotavirus vaccine strains i.e Rotateq and Rotarix. Reference strains, vaccine strains and
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Distribution of Rotavirus Infection and G/P Genotypes by
Age and Sex
The median age of all rotavirus infected children (9.6 months)
was significantly lower than that of rotavirus uninfected children
(10.7 months, P = 0.003). There was no significant difference in
the median age of rotavirus infected children with and without
diarrhea (9.6 months vs. 9.7 months). Figure 3 shows that the
prevalence of rotavirus infection in cases was significantly higher in
the age group of 0–6 months compared to the age group $19
months (35.1% vs. 23.4%, P = 0.028, OR 2.14, 95% CI: 1.09 to
4.23). The prevalence of rotavirus infection did not differ
significantly between age groups 7–12 and 13–18 months
respectively, as compared to age group $19 months. The
prevalence of rotavirus infection in controls did not differ
significantly between age groups (P.0.05). Rotavirus genotypes
G1 and G8 were detected in all age groups, whereas G4 was
detected in the age of 0–12 months and one strain of G9 was
detected from a child in the group of 0–6 months.
The proportion of rotavirus infection in all children with and
without diarrhea did not differ significantly by sex as shown in
Table 3.
The distribution of rotavirus G and P genotypes was not
significantly associated with sex of the child, presence of
dehydration, nutritional status or HIV status (P.0.05).
Discussion
Rotavirus is the leading cause of severe diarrhea both in
developed and developing countries. This one-year surveillance
study described the molecular epidemiology of rotavirus infection
in children in Dar es Salaam, the major city of Tanzania with a
population of about five million inhabitants. Children with
diarrhea were six times more likely to be infected with rotavirus
than those without diarrhea. The study confirms findings from
other studies twenty years ago in the same location and elsewhere
[42,44] indicating that rotavirus is still a major pathogen causing
diarrhea in children in Tanzania. The presence of rotavirus
among controls may represent reservoirs for transmission in the
community.
In the current study, five G and three P genotypes were
detected. Rotavirus G1[P8] was the most prevalent G/P
combination and this genotype combination is reported to be
responsible for 50–65% of rotavirus infections in children
worldwide [45]. Since more than 60% of the study subjects were
affected by this genotype combination, which is in the current
vaccine introduced in Tanzania (Rotarix), we assume that the
vaccine will be protective, given that the circulating genotype is
stable. Rotavirus G8 was the second most common genotype in
this study and this is the first time it is reported in Tanzania. Of
note is the fact that all the G8 strains detected were initially
genotyped as G12 by multiplex and semi-nested PCR using
primers described in the European Rotavirus Detection and
Typing Methods version 4 [39]. The G8 genotype-specific primers
were compared to nucleotide sequences of the G8 viruses isolated
in this study, and three to four primer mismatches were found
predominantly in the 39end. When G12 genotype-specific primers
were compared to G8 sequences we found that the numbers of
mismatches were fewer and in less critical positions than the
unintended mismatches for the G8 specific primers. Consequently,
in samples containing G8 genotype viruses, none of the primers
had perfect match, and the G12 primers by chance obtained the
strongest binding producing a false positive G12 result. Due to the
higher mutation-rates in viral genomes, PCR based typing
strategies will generally be more error-prone than typing based
on sequencing. This can result in erroneous epidemiological data
and a poor foundation for further vaccine research. Other studies
have also documented mistyping of rotavirus strains by multiplex
RT-PCR [20,46–48]. We suggest that caution should be taken
when interpreting the results of rotavirus G genotypes based on
multiplex PCR. Furthermore these findings emphasize the higher
robustness obtained by sequencing for typing of rotaviruses.
strains from this study are indicated by accession numbers. The Genius software package was used to build the tree with the UPGMA method and
bootstrapped with 1,000 repetitions; The Kimura-2 substitution model was used. The bar indicates nucleotide substitutions per site.
doi:10.1371/journal.pone.0097562.g001
Figure 2. Seasonal variation of rotavirus infection and G genotypes among children admitted with diarrhea. The graph shows the total
number of rotavirus infected children admitted due to diarrhea (cases) per month with G genotypes.
doi:10.1371/journal.pone.0097562.g002
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Genotype G12 was previously documented by sequencing only
in three African countries, namely Malawi, South Africa and
Nigeria [18–20]. The present study is the first documentation of
genotype G12 in Tanzania.
Surprisingly we found only one strain of G9 in combination
with P[8] in the current study, while this genotype predominated
in the same study setting 8 years earlier [36]. This emphasizes the
need for continuous rotavirus strain surveillance.
Apart from defining the serotype of rotavirus, G proteins are
critical to vaccine development because they are targets for
neutralizing antibodies that are believed to be important for
protection. The two current rotavirus vaccines i.e RotaTeq (RV5)
and Rotarix (RV1) can control infection against the five main
rotavirus genotypes, which are G1, G2, G3, G4 and G9 [49].
Phylogenetic analysis was performed to show the relationship
between the Tanzanian G1P[8] and vaccine strains in the Rotarix
and RotaTeq vaccines. Our results revealed that the Tanzanian
G1P[8] strains are distantly related to G1P[8] of the vaccine
strains. This suggests that circulating G1P[8] strains may have
changed over time through accumulated mutations making them
different from original vaccine strains which were isolated over
twenty six years ago [49,50]. In this study we report a significant
increase in the prevalence of P[6] and P[4] rotavirus positive
samples compared to the previous study in the same region [36].
Rotavirus samples with P[6] in this study were associated with a
variety of G-genotypes (G4, G8, and G12). Phylogenetic analysis
revealed that rotavirus P[6] in this study is closely related to P[6]
from other African countries such as Malawi and South Africa.
The high prevalence of rotavirus genotypes not included in the
current rotavirus vaccines i.e. G8, G12, P[4] and P[6] in this study
and other studies from developing countries may be one of the
reasons for the reported lower vaccine efficacy in developing
countries [51]. The Tanzanian G1P[8] variant may be able to
escape from vaccine induced immunity [50]. However other
possible contributing factors such as maternal antibodies and
change in gut microbiota needs to be investigated [52,53]. No
multiple rotavirus infection of G or P genotypes was detected in
this study, which concurs with the previous findings in the same
study setting [36]. In this study, rotavirus showed significant
variation of prevalence in different months of the year with a peak
Table 2. Summary of studies on rotavirus in Dar es Salaam, Tanzania.
Brookfield et al 1979[41] Mhalu et al 1988[43] Sam et al 1992[42] Moyo et al 2007[36] Current study 2014
Prevalence of rotavirus 31% 19.5% 43% 18.1% 32.5%
Type of subjects Inpatients Inpatients Inpatients Inpatients Inpatients
Months of data collection Mar1976–Sept 1976 Jan 1987–Feb 1987 May 1988–Aug 1988 Dec 2005–Feb 2006 Aug 2010–Jul 2011
Age group studied ,7 yrs ,3 yrs ,3 yrs ,5 yrs ,2 yrs
Method for detection EM Latex agglutination EM+ latex agglutination ELISA+PCR ELISA+PCR
doi:10.1371/journal.pone.0097562.t002
Figure 3. Prevalence of rotavirus infection in different age groups. The graph shows the prevalence of rotavirus from ELISA results per age
group in cases and controls.
doi:10.1371/journal.pone.0097562.g003
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of rotavirus infection during the cooler months of the year. The
seasonal variation observed in the current study is further
supported by findings from previous studies from the same region
[36,41–43]. Studies conducted during cool months of the year
[41,42] found high prevalence of rotavirus compared to studies
conducted during hot months of the year [36,43]. Understanding
seasonal patterns of rotavirus will be useful when considering the
appropriate timing of immunization booster programs in settings,
which have reported poor efficacy of rotavirus vaccine and have
demonstrated strong seasonality. Rotavirus vaccine administration
in the current Extended Program on Immunization schedule in
developing countries is at 6, 10, and 14 weeks of age. However, if
booster vaccination programs were to be considered for older
children lacking immunity, vaccination during the pre-rotavirus
season is recommended [34].
In this study we found significantly lower incidence of rotavirus
in HIV-positive children compared to HIV-negative children with
diarrhea. This supports findings of previous studies in Tanzania
and other developing countries where rotavirus is detected less.
frequently or not detected at all among HIV-positive children
with diarrhea [54–59]. On the other hand rotavirus was more
prevalent among HIV-positive children than HIV-negative
children without diarrhea. More studies are needed to clarify this
issue.
Rotavirus diarrhea occurs at an earlier age among children in
developing countries than children in industrialized countries. The
mean age of rotavirus infection in this study compares with the
mean age of rotavirus gastroenteritis in other developing countries
which ranges from 6–9 months [60]. However the rotavirus
prevalence of 27.8% in children less than three months is notably
high with non-vaccine serotypes also found i.e. G8 and G12. This
may have implications for the rotavirus vaccine introduced in the
study setting; first, this age group may not fully benefit from the
immunization programme, since the first dose is given at 6 weeks;
secondly these infants may have acquired immunity from natural
infection with rotavirus prior to immunization and therefore the
ability to measure vaccine efficacy in the study setting may be
impaired.
Conclusion
This study showed a switch from G9 genotype during the past 8
years to G1genotype dominance in this study, and a low similarity
between the Tanzanian G1 genotype and the vaccine G1geno-
type. We have also observed unusual circulating genotypes G8 and
G12 for the first time in Tanzania. Since early 2013, the rotavirus
vaccine Rotarix has been introduced and included in the Extended
Program of Immunization (EPI) in Tanzania. The present study
represents pre-vaccination data and may be useful in the future
when assessing the effectiveness of the vaccine. This study also
showed seasonal variation in the prevalence of rotavirus. Rotavirus
seasonality provides insights important for vaccination strategies,
including potential shifts in seasonal peaks and duration of
outbreaks. Our data also support the notion that rotavirus may
not be an opportunistic pathogen in children infected with HIV.
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